Advertisement
NRx Pharma Says FDA Grants Permission To Proceed On IND For NRX-101 To Treat Chronic Pain
(RTTNews) - Biopharmaceutical company NRx Pharmaceuticals, Inc. (NRXP) announced Monday that FDA has given the company clearance to proceed with human trials to treat Chronic Pain under the Investigational New Drug (IND) application filed with the U.S. Food and Drug Administration (FDA) for the use of NRX-101.
The IND application leverages pioneering research on the use of D-cycloserine (a key ingredient of NRX-101) in the treatment of chronic pain and the recent licensure by NRx of a US Patent for the use of D-cycloserine in the treatment of pain.
The company said it is looking forward to initiate commercial development of NRX-101 to treat chronic pain. It also plans to seek Fast Track Designation, Priority Review, and Breakthrough Therapy Designation for this critical indication.
read more
NRx Pharma Achieves Data-lock In Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study
Biopharmaceutical company NRx Pharmaceuticals, Inc. (NRXP) announced Monday that it has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study with NRX-101. With data-lock, the complete data set is transferred for independent statistical analysis. The top-line data release is expected in April 2024.
RTTNews
|
499 дней спустя
NRx Pharmaaeuticals To Receive First $5 Mln Milestone Payment From Partners Alvogen And Lotus Pharma
Biopharmaceutical company NRx Pharmaceuticals, Inc. (NRXP) announced Monday the advance of the first $5 million milestone payment based on the Company's partnership agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.
RTTNews
|
555 дней спустя
Fed Minutes Reveal Details Behind Split Interest Rate Decision
The minutes of the Federal Reserve's latest monetary policy meeting revealed most officials still see the upside risk to inflation as the bigger threat to the economic outlook, although a couple were more worried about the downside risk to employment.
RTTNews
|
1ч 58мин назад
TSX Modestly Higher As Materials, Energy Stocks Gain
The Canadian market is modestly higher Wednesday afternoon, lifted by strong gains in materials and energy sectors.
The mood remains a bit cautious ahead of the Federal Bank's symposium in Jackson Hole, Wyoming, where several central bank chiefs including Fed Chair Jerome Powell are set to make speeches.
RTTNews
|
2ч 13мин назад
Swiss Market Ends On Firm Note
After a weak start and a subsequent drop to lower levels, the Switzerland market recovered and stayed subdued till around mid morning on Wednesday, but kept edging higher as the day progressed to eventually ended the session on a firm note.
Optimism about a potential peace deal between Russia and Ukraine supported the market.
RTTNews
|
2ч 40мин назад
European Stocks Closed On Mixed Note
European stocks turned in a mixed performance on Wednesday after another cautious session, as investors looked ahead to the Federal Reserve's Jackson Hole Symposium that gets underway on Thursday, and continued to focus on the developments on the trade and geopolitical front.
RTTNews
|
2ч 55мин назад
Target Q2 Down, Yet Beats Street, Backs FY25 View, Names Michael Fiddelke CEO; Shares Hit
Shares of Target Corp. were losing around 11 percent in the pre-market activity on the NYSE, after the retail major reported Wednesday lower profit and comparable sales in its second quarter. However, earnings per share and top line beat market estimates, and the firm maintained its fiscal 2025 outlook. Separately, Target announced the appointment of Michael Fiddelke, chief operating officer,
RTTNews
|
7ч 26мин назад
Indonesia Unexpectedly Cuts Interest Rate
Indonesia's central bank eased its monetary policy unexpectedly on Wednesday in order to bolster economic growth amid inflation remaining well within the target range. The Bank Indonesia board, led by Governor Perry Warjiyo, decided to cut the BI rate by 25 basis points to 5.0 percent.
RTTNews
|
7ч 51мин назад
